|
Market Cap (24-Jun) $229,103,600 (1,730th) |
Close (30-Jun) $0.020 |
Volume (30-Jun) 31,196 |
Shortsold (26-May) 1,000,000 (0.04%) (508th) |
|
52w High $0.110 |
52w Low $0.030 |
P/E 19.69 |
EPS 0 |
BXN released this announcement to the ASX on 30 June 2022, 17:19. The announcement is not marked as price sensitive, and is 2 page(s) in length and 149.94kb in size.
You can view all announcements from BXN and see how they appear on a price chart on the announcements page.
At the date of this announcement, BXN was 0.000% short sold according to ASIC data. It was ranked the 595th most shorted stock on the ASX. It is now ranked as the 508th most shorted stock on the ASX with 0.044% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from BXN | |
|---|---|
| Bioxyne Launches BLS Clinics - Online Healthcare | 13 June 2023, 9:05 |
| Becoming a substantial holder | 8 June 2023, 16:36 |
| Becoming a substantial holder | 31 May 2023, 17:30 |
| Initial Director's Interest Notice | 30 June 2022, 17:19 |
| Final Director's Interest Notice | 30 June 2022, 17:18 |
| Board and Management Changes | 8 June 2022, 8:57 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2022, 8:19 |
You must be logged in to post a reply.
Bioxyne 